Trial intelligence / Profile preview

Post-marketing safety and effectiveness of inactivated EV71 vaccine (human diploid cell) in Chinese children

CTR20160594Phase 4Active

Sponsor
Institute of Medical Biology
Start
Jan 2017
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Inactivated enterovirus 71 vaccine (KMB-17) in enterovirus 71 infection, sponsored by Institute of Medical Biology. Started Jan 2017; status: active.

02

Drugs

Inactivated enterovirus 71 vaccine (KMB-17)
03

Conditions

enterovirus 71 infection

Beyond the preview

Go deeper on CTR20160594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call